Evidence map›Paper›PMID 42399733›Full record

ArticleChirality2026

Enantioselective Crystal Growth Induced by Mesoscopic Helical Platforms.

Anthony Boudier, Guillaume Raffy, Emilie Pouget, Sylvain Nlate, Dario M Bassani, Reiko Oda

Abstract read
In one paragraph

Article in Chirality, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Anthony BoudierUniv. Bordeaux, CNRS, Bordeaux INP, CBMN, UMR 5248, Pessac, France.
Guillaume RaffyUniv. Bordeaux, CNRS, Bordeaux INP, ISM UMR 5255, Talence, France.
Emilie PougetUniv. Bordeaux, CNRS, Bordeaux INP, CBMN, UMR 5248, Pessac, France.
Sylvain NlateUniv. Bordeaux, CNRS, Bordeaux INP, CBMN, UMR 5248, Pessac, France.
Dario M BassaniUniv. Bordeaux, CNRS, Bordeaux INP, ISM UMR 5255, Talence, France.ORCID https://orcid.org/0000-0002-9278-1857
Reiko OdaUniv. Bordeaux, CNRS, Bordeaux INP, CBMN, UMR 5248, Pessac, France.ORCID https://orcid.org/0000-0003-3273-8635

Funding

Agence Nationale de la Recherche ANR-21-CE09-0012-02Agence Nationale de la Recherche ANR-23-EXLU-0004Bordeaux UnivCentre National de la Recherche ScientifiqueIdex Bordeaux GPR-LIGHTJSPS Core-to-Core Program JPJSCCA20250005Université de Bordeaux
6 · The paper itself

Abstract

We report enantioselective crystallization of tetraphenylethylene (TPE) directed by chiral silica nanohelices (SNHs), yielding crystalline assemblies with distinct morphologies and chiroptical signatures that are modulated by both template handedness and evaporation kinetics. When TPE solutions are deposited onto SNH-functionalized substrates and allowed to crystallize through slow solvent evaporation at 4°C, small orthorhombic crystals (2-5 μm) form with strong induced electronic circular dichroism (ECD) and circularly polarized luminescence (CPL) whose sign is correlated to the underlying SNH handedness. In contrast, rapid evaporation at room temperature leads to dendritic crystalline assemblies with strong ECD but weaker CPL with reduced correlation to the template handedness. Fluorescence microscopy confirms that emission originates exclusively from crystalline domains, consistent with restriction of intramolecular rotation upon crystal packing. The results show that right-handed (P-) and left-handed (M-)SNH preferentially promote the formation of distinct TPE enantiomeric crystals, providing a robust platform for template-directed chirality-controlled crystallization.

Indexed as

chirality inductionenantioselective crystal growthmesoscopic helical structure

Identifiers

PMID42399733
PMCPMC13331963

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.